Clinical Trial Update: OCT Study of the MGuard Prime Stent in Patients With Heart Attacks [Phase 4]

View source ↗

Summary

An OCT study of the MGuard Prime Stent in ST-elevation myocardial infarction patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• MGuard Prime Stent

Snippet

Sponsor: InspireMD | Conditions: ST Segment Elevated Myocardial Infarction | Phase 4 | Status: WITHDRAWN